Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05011370 · ClinicalTrials.gov registry record
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
A clinical trial, sponsored by Protara Therapeutics.
- Completed
- Registry status
- 80
- Enrollment target
NCT05011370 is a clinical trial that has completed, run by Protara Therapeutics. The registered enrollment target is 80 participants.
The verdict
NCT05011370 has completed, sponsored by Protara Therapeutics.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This is a multi-center prospective cross-sectional observational study that will assess the prevalence of liver disease in patients dependent on parenteral nutrition (PN) for 4 or more days per week. Liver disease will be determined by the presence of choline deficiency, cholestasis (confirmed by elevated serum alkaline phosphatase (ALP) liver isoenzyme level), and steatosis (confirmed by magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF). The objective of this study is to investigate the presence/prevalence of liver disease in patients dependent on PN (≥4 days a week).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2023-06-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05011370
The ClinicalTrials.gov registry entry for NCT05011370 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Protara Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05011370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05011370 about?
NCT05011370 is a clinical study titled "Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition". This is a multi-center prospective cross-sectional observational study that will assess the prevalence of liver disease in patients dependent on parenteral nutrition (PN) for 4 or more days per week. Liver disease will be determined by the presence of choline deficiency, cholestasis (confirmed by el...
What is the current status of trial NCT05011370?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2021-08-23. Estimated completion is 2023-06-29.
Who is sponsoring clinical trial NCT05011370?
This trial is sponsored by Protara Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.